Illumina Inc. (NASDAQ:ILMN) ranks among the top NASDAQ stocks with low P/E ratios. On September 23, Illumina Inc.

Analysts have set 12-month price targets for Illumina, revealing an average target of $106.56, a high estimate of $128.00, and a low estimate of $80.00. Witnessing a positive shift, the current ...

The GATE Biotechnology exam consists of three sections, i.e., General Aptitude, Engineering Mathematics, and core Biotechnology subjects. The weightage of General Aptitude and Engineering Mathematics ...

AI is revolutionizing the IVD market by enhancing diagnostic accuracy and speed. Key opportunities lie in AI integration across workflows, cloud solutions, regulatory support, and supply chain ...

The oncology-based molecular diagnostics market is being propelled by the increasing prevalence of cancer worldwide and the ...